Category Healthcare Economics

Long-term Benzodiazepine Use and Negative Socioeconomic Outcomes: Are physicians to blame?

In early 2014 I participated in a health care economics course led by University of Colorado-Denver healthcare economist Andrew Friedson. Throughout this course we surveyed topics in healthcare economics and reviewed related economic literature with a focus on how certain econometric techniques are applied in practice. I walked away adept in reviewing economic literature and enjoyed a fantastic opportunity to write a research proposal that comments on an under-addressed topic in medical malpractice literature.

Most likely you’ve heard of pharmaceuticals such as Ambien, Xanax, and Klonopin. These and many other related drugs are psychoactive compounds known as benzodiazepines; these are prescription drugs frequently used to treat insomnia, anxiety, and depression...

Read More